Pharmaceutical Intelligence

In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026 by sjwilliamspa In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 Reporter: Stephen J. Williams, Ph.D. Source: https://www.aacr.org/professionals/membership/in-memoriam/ The following remembrances of American Association of Cancer Research (AACR) prominent member who have recently passed in 2026 is given below.

To the Membership of Life Sciences PA: Today, we are urging you to contact your United States members of Congress on Office of Management and Budget (OMB) proposed revisions to “Guidance for Federal Financial Assistance.” You can do so through the Life Sciences PA Advocacy Action Center. The OMB proposal, which is currently accepting public comments, would make significant changes to how research funding decisions are administered across federal agencies, including the NIH and NSF.

Reporter: Stephen J. Williams, Ph.D. From the Tang Prize Committee Anouncement Source: https://www.tang-prize.org/en/media_detail.php?id=2097 On June 16, the Tang Prize in Biopharmaceutical Science announced its 2026 laureates. The prize, whose laureates from previous cycles have subsequently received Nobel Prize honors, has drawn wide international attention. Three leading scientists in the field of cellular immunotherapy, Drs. Steven A. Rosenberg, Michel Sadelain, and Carl H.

This content is password-protected. To view it, please enter the password below.

Tumor Infiltrating Lymphocytes (TIL) as a first of kind FDA approved immunotherapy for cancer June 12, 2026 by sjwilliamspa Reporter: Stephen J.

Curators: Aviva Lev-Ari, PhD, RN and Grok/xAI This post presents a systematic, day-by-day analysis of the daily newsletters published by Alex Wissner-Gross, Investor and Entrepreneur, covering the period from March 1, 2026 through June 10, 2026, and extended to the present. This body of work represents a new format of Hybrid Scientific Reporting for LPBI Group. It combines continuous real-time observation of the AI revolution with structured strategic reasoning and documentation.

In Memoriam: Professor Yitzhak Apeloig, President and Distinguised Professor of the Technion June 4, 2026 by sjwilliamspa Reporters: Aviva Lev-Ari, PhD, RN and Stephen J.

My first 2026 ranking of the top investors in global unicorns is live. Sequoia is still #1 — but the list looks very different from the US one. We rank investors by the number of unicorns worldwide they backed before the company reached unicorn status.

Grok thinks like PhDs – Hybrid Model for Autonomous Update of Doctoral Dissertations with Original PhD Student Author editing and acceptance of Grok’s updated output. 3rd Joint article, a pilot study for Validation of an Autonomous Journal Articles Updating System (AJAUS) tested on Autonomous Update of Aviva Lev-Ari, PhD, RN Doctoral Thesis, UB, Berkeley, 1983.

Aviva Lev-Ari @AVIVA1950 · Jan 23 Great reservation expressed by @RuslanVolkov25 Quote Ruslan Volkov @RuslanVolkov25 · Jan 22 Replying to @ShaneLegg Every time I hear “AGI is just around the corner,” I feel two things at once: amusement – and embarrassment for humanity.